chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No adverse events; patient was administered an improperly stored dose of VARIVAX; This spontaneous report was received from a registered nurse and refers to a patient of unknown age. Information regarding the patient's pertinent medical history, drug reactions/allergies was not reported. On 27-FEB-2020, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (lot # S002395; expiry date: 23-JAN-2021), (strength, dose, route of administration and anatomical location were not reported) for prophylaxis (product storage error). The vaccine was stored at a temperature of 13.8°C for a time frame of 1 hour 45 minutes. There was no previous temperature excursion. The call was because of a data logger. No adverse effects provided. The outcome of the events was unknown.
Swelling in lymph nodes under armpit. Pain at level 6 in lymph node arm in injection site.
Brain fog; Burning pain in both arms and body; Vomiting; Nausea; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205), via an unspecified route of administration in the right arm on 03Mar2021 (at the age of 30-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730), via an unspecified route of administration in the left arm on 25Mar2021 (at the age of 30-years-old), as single doses for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication included cetirizine hydrochloride (ZYRTEC) for an unknown indication from an unknown date. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date in Mar2021, the patient experienced vomiting, nausea, brain fog and burning pain in both arms and body. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events vomiting, nausea, brain fog and burning pain in both arms and body. The clinical outcomes of the events vomiting, nausea, brain fog and burning pain in both arms and body were not recovered at the time of the report. No follow-up attempts are possible. No further information is expected.
This is what my report says for the vaccination given. It was for the flu but I do not know the exact name: Influenza, injectable, MDCK, preservative free, quadrivalent. Left Arm does not have full mobility without soreness. Very sore in injection site. After 2 weeks of pain, left message for the doctor. The doctor said to come in the next day. I was prescribed the Zpack and was told to have an ultrasound of my left arm to rule out blood clots. I had an ultrasound the following day on 10/10/2017 (US, Duplex, Venous, Upper Extremity) and there were no blood clots. I was given PT Exercises to do at home and was told that there was an underlying situation with my shoulder prior to the vaccination because the doctor pushed in an area under my armpit and it was sore. I have never had pain in my left arm/shoulder prior to the vaccination. It has been 3 weeks and I have the same amount of pain in my arm/shoulder. I wake up at night because it is difficult to move my arm and is very painful. Patient Care Summary Most Recent Encounter 10/12/2017 Reason for Visit f/u flu shot reaction. Assessment and Plan. The following list includes any diagnoses that were discussed at your visit. 1. Sprain of shoulder rotator cuff. ? rotator cuff: exercises ? rotator cuff injury: care instructions ? rotator cuff problems: care instructions ? rotator cuff strengthening.
On 3/31/21 pt reports feeling "achy, like a wet blanket", headache, Restless and up every hour of the night. "I felt like a freight train ran over me. " Treated for a sinus infection with Z-Pak.  Notified he was covid (+) on 4/2/21.  Fever, chills, dyspnea.
She was in bed because she didn't have any energy; couldn't eat or drink anything; She was tired for a while; She was very sick for two days after the second dose; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (She was in bed because she didn't have any energy), FEEDING DISORDER (couldn't eat or drink anything), ILLNESS (She was very sick for two days after the second dose) and FATIGUE (She was tired for a while) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Cancer (Patient has been doing well with Keytruda but she has not eliminated cancer), Celiac disease and Gastrointestinal motility disorder NOS (Motility issues). Concomitant products included PEMBROLIZUMAB (KEYTRUDA) for Cancer.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ILLNESS (She was very sick for two days after the second dose). On an unknown date, the patient experienced ASTHENIA (She was in bed because she didn't have any energy), FEEDING DISORDER (couldn't eat or drink anything) and FATIGUE (She was tired for a while). On 17-Mar-2021, ILLNESS (She was very sick for two days after the second dose) had resolved. At the time of the report, ASTHENIA (She was in bed because she didn't have any energy), FEEDING DISORDER (couldn't eat or drink anything) and FATIGUE (She was tired for a while) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: high (High) She did an antibody test, and she had a higher level than normal people would.         Patient was very sick for two days after the second dose. It started that night on 15Mar2021. It was not surprising that she could not eat or drink anything. She was in bed because she did not have any energy. It lasted for few days. Then she came out of it. She was tired for a while.   Treatment information was not provided.
22NOV feels hot; 25NOV felt warm & sl nauseated x approx 2 hrs;
Sore left arm for 2 days; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date(at the age of 61-years-old) as a single dose for COVID-19 immunisation and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 11Mar2021 at 13:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The medical history and concomitant medication was not reported. On an unknown date, the patient experienced sore left arm for 2 days. The clinical outcome of the event sore left arm for 2 days was recovered on unknown date.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
LOCAL ERYTHEMA AND PAIN,  MANAGED WITH IBUPROFEN AND COLD COMPRESSES
Got out of bed to go to bathroom. Felt very dizzy and weak. Lowered myself to floor to avoid bad fall. Drenched with cold sweat and very nauseated. Arm of shot site extremely painful. Difficult to lift arm. Made it back to bed. Slept OK. Same thing happened (above: weakness, etc.) when I got up the next a.m. Symptoms not quite as severe but still had nausea & cold sweats, weakness, shakiness.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. The patient's medical history, concomitant medications and drug allergies were not specified. On an unknown date, the patient was vaccinated with a properly stored PNEUMOVAX 23 lot # N013521, expiration date 23-JAN-2019, one dose (reported as one shot) for prophylaxis. On an unknown date, after administration of PNEUMOVAX 23, the patient was unable to move her arm for three days. The patient had discomfort, pain, swelling and hot sensation around injection site. Due to the events, she received unspecified treatment. The patient did not seek medical attention. The outcome of the events was reported as recovered/resolved. The relatedness between PNEUMOVAX 23 and the events was not specified. This is one of three reports received from the same reporter.; Sender's Comments:  US-009507513-1710USA007749: US-009507513-1710USA007750:
I only had a sore arm with  second booster dose of the Pfizer Covid 19 vaccine as well as the flu shot each year; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 79-year-old female patient received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; influenza vaccine (FLU), (Batch/Lot number: unknown). The patient's relevant medical history included: "kidney failure" (unspecified if ongoing), notes: had third stage kidney failure; "overweight" (unspecified if ongoing), notes: 90 lbs overweight; "a-fib" (unspecified if ongoing), notes: a-fib. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (primary series immunization completed , unknown manufacturer, Booster Dose), for Covid-19 Immunization; Covid-19 vaccine (primary series immunization completed , unknown manufacturer), for Covid-19 Immunization; Flu shot (Flu shot, Stated that she gets the sore arm with her annual flu shot each year), reaction(s): "sore arm".  The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "I only had a sore arm with  second booster dose of the Pfizer Covid 19 vaccine as well as the flu shot each year".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
arm is extremely sore; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (patient).  A female patient of unknown age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on 13Jan2021 at single dose for COVID-19 immunisation. Medical history and concomitant medications were unknown. On 13Jan2021, she said that her arm is extremely sore. Caller would like to know if she can take Ibuprofen or something that may help with the pain. Outcome was unknown.  Information on the lot/ batch number has been requested.
had gotten the shingles shot. Then got shingles /suspected vaccination failure; shingles; This case was reported by a other health professional via interactive digital media and described the occurrence of suspected vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that, before i retired from the hospital, met a lot of people who had gotten the shingles shot, then they got shingles. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.
Discharge Physician: DO Primary Care Physician: MD  Date of Admission: 8/1/2023 Discharge Date: 8/6/2023 Room Number: 2025/2025-1 DETAILS OF HOSPITAL STAY:   PRESENTING PROBLEM: ARF (acute renal failure) (HCC) [N17.9] AKI (acute kidney injury) (HCC) [N17.9] Trimalleolar fracture, left, closed, initial encounter [S82.852A] Open trimalleolar fracture, left, sequela [S82.852S] COVID-19 virus infection [U07.1]   72-year-old woman with a past medical history of type 2 diabetes, CKD 3, hypertension who presented after being sent home from a recent trimalleolar fracture.  Patient had been instructed to follow up outpatient with Orthopedic surgery as an outpatient after she had a splint placed in the emergency department.  However, when she returned home the skin broke and she experienced bleeding that soaked through her splint and dressing.  When she presented back to the emergency department labs were drawn which revealed a creatinine of 3.11.  She was also she COVID positive after describing a few days of body aches, sore throat, upper respiratory symptoms. She had poor PO intake but had continued to take her home lasix.  Pt was hypoxic on arrival, so placed on decadron and remdesivir. Patient was able to be weaned quickly off oxygen and remained on room air for the remainder of her admission.   Patient was aggressively fluid resuscitated due to acute kidney injury.  She went to the OR on 08/02/2023 for open reduction external fixation of her ankle fracture.  Renal function initially improved but not significantly over the course of 2-3 days.  Nephrology was contacted on 08/04 who recommended initiation of Lasix diuresis 40 mg IV twice daily as well as an echocardiogram. Patient renal function declined after initiation of diuretics. Patient was transferred to Butterworth for a formal nephrology evaluation. Case was discussed with ortho trauma prior to transfer so they could arrange to follow/evaluation her at the receiving facility. Patient was in agreement with the plan and she was transferred in stable condition.
Fever up to 101.4 Headaches  Body Aches Chills Fatigue
Mom noted itching of R deltoid area as well as heat in the evening.  This morning, noted that it persisted.  Seen today for PPD read.  PPD negative, but also noted to have persistent itching, redness, swelling near R deltoid area measuring about 9.5x 9 cm.  Non-tender, warm to touch.  Otherwise, normal exam.  Treated mainly with ice at home.  Started treatement with oral anithistamines after clinic visit.
pt recv vax 27JAN99 & 1FEB99 had several minute focal sz which has subsequently re-occurred;pt adm to hosp;extensive work up nl;neurology consulted;Annual follow-up received on 02/21/01 provided no additional data.
22NOV95 mom called hlth unit & has MD appt;pt cried w/high pitch voice from noon to 8PM on 21NOV95 & lt leg swell up real bad;tried warm compress & Tempera;stopped when felt asleep @ 10PM;mom brought pt to ER MD told mom to report to hlth
Diagnosis- Polymyalgia Rheumatica; Diagnosis-Giant Cell Arteritis; headaches; shoulder pain/achy hips; neck pain; couldn't drive for more than an hour; This case was reported by a nurse via call center representative and described the occurrence of polymyalgia rheumatica in a 75-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th April 2022, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. In May 2022, 3 weeks after receiving Shingrix, the patient experienced polymyalgia rheumatica (serious criteria GSK medically significant), giant cell arteritis, headache, shoulder pain, neck pain and driving ability disturbed. The patient was treated with steroids nos (Steroid (Not Specified)). On an unknown date, the outcome of the polymyalgia rheumatica, giant cell arteritis, headache, shoulder pain, neck pain and driving ability disturbed were recovered/resolved.   It was unknown if the reporter considered the polymyalgia rheumatica, giant cell arteritis, headache, shoulder pain, neck pain and driving ability disturbed to be related to Shingrix.   Additional Information: GSK Receipt Date: 12-SEP-2022 Reporter's Comment: The case was reported by the nurse and patient's wife. The patient received Shingrix in left deltoid and 3 weeks after that he experienced headaches, shoulder and neck pain, achy hips and could not drive for more than an hour.  He went to his primary care physician, neurologist, and finally his rheumatologist who diagnosed him with polymyalgia rheumatica and giant cell arteritis.  He was relieved with steroids (injections and pills). The Healthcare professional consented to follow up. The reporter consented to follow up.
Bells Palsy diagnosed on 5/31/2021. Steroid and antiviral medication.  Pulmonary embolism on 6/9/2021. EKOS procedure on 6/10/2021. Heparin IV for 3 days. Oral medication eliquis prescribed.
Received MCV4 in pm on 6/11/08 at 2 am 6/11/08 awoke and c/o nausea and severe HA with temp 102 deg Sx not resolved with TYLENOL migraine also reported. Awoke with whole body, feeling like it is on fire. Denies any localized pain, redness, or inflammation to injection site. To see doctor 1:30 pm to go to ER if s/sx worsen.
it was a very itchy rash; on the weekend woke up with a terrible severe rash on the leg and neck, by Sunday was it itching so bad that just sit and watched tv and scratched so bad that it bleed; on the weekend woke up with a terrible severe rash on the leg and neck, by Sunday was it itching so bad that just sit and watched tv and scratched so bad that it bleed; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of RASH PRURITIC (it was a very itchy rash), PRURITUS (on the weekend woke up with a terrible severe rash on the leg and neck, by Sunday was it itching so bad that just sit and watched tv and scratched so bad that it bleed) and WOUND HAEMORRHAGE (on the weekend woke up with a terrible severe rash on the leg and neck, by Sunday was it itching so bad that just sit and watched tv and scratched so bad that it bleed) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     Previously administered products included for Drug allergy: penicillin since an unknown date. Concurrent medical conditions included Drug allergy (Tylenol, advil). Concomitant products included HYDROCHLOROTHIAZIDE for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (it was a very itchy rash), PRURITUS (on the weekend woke up with a terrible severe rash on the leg and neck, by Sunday was it itching so bad that just sit and watched tv and scratched so bad that it bleed) and WOUND HAEMORRHAGE (on the weekend woke up with a terrible severe rash on the leg and neck, by Sunday was it itching so bad that just sit and watched tv and scratched so bad that it bleed). At the time of the report, RASH PRURITIC (it was a very itchy rash), PRURITUS (on the weekend woke up with a terrible severe rash on the leg and neck, by Sunday was it itching so bad that just sit and watched tv and scratched so bad that it bleed) and WOUND HAEMORRHAGE (on the weekend woke up with a terrible severe rash on the leg and neck, by Sunday was it itching so bad that just sit and watched tv and scratched so bad that it bleed) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treated with itch medicine and steroids shot.
Pain; Nausea; Vomitting; Body Aches; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), NAUSEA (Nausea), VOMITING (Vomitting), MYALGIA (Body Aches) and HEADACHE (Headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN (Pain), NAUSEA (Nausea), VOMITING (Vomitting), MYALGIA (Body Aches) and HEADACHE (Headache). The patient was treated with IBUPROFEN at a dose of 1 dosage form and OXYCODONE HYDROCHLORIDE, OXYCODONE TEREPHTHALATE, PARACETAMOL (PERCOCET [OXYCODONE HYDROCHLORIDE;OXYCODONE TEREPHTHALATE;PARACETAMOL]) at a dose of 1 dosage form. At the time of the report, PAIN (Pain), NAUSEA (Nausea), VOMITING (Vomitting), MYALGIA (Body Aches) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jan-2021: Follow up received on 24-JAN-2021. No new information was reported. On 18-Feb-2021: NO new information
Fever of 101F next day post-vaccination. Tylenol was given and Cefuroxime iv with observation.
Caller reports her 4 year old daughter stated part of the child's PROQUAD vaccine leaked out of the child's arm at time of vaccination.; PROQUAD vaccine leaked out of the child's arm at time of vaccination.; This spontaneous report was received from a consumer (patient's mother), referring to a 4-year-old female patient. The patient's pertinent medical history, concomitant medications and drug reactions/allergies were not reported.   On an unknown date in October 2022 (reported as "end of October 2022"), the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection for prophylaxis (dose, strength, lot #, expiration date and route of administration were not provided), but part of the vaccine leaked out of the patient's arm at time of vaccination (injection site discharge; incorrect dose administered). The patient's mother was unable to provide site of administration as she was not at appointment but did report child had a band aid on her right arm. The patient's mother reported child's father was at visit where vaccine was administered and did not report leakage from site of vaccination. The patient's mother wished to confirm if her daughter received an adequate dose. She requested any information available about her child needing revaccination. At the time of reporting, the outcome of the event injection site discharge was unknown.   The causal relationship between injection site discharge and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was unknown.
Information has been received from a nurse practitioner concerning a 22 year old female who in approximately 2006, about 4 years ago, was vaccinated with an unknown hepatitis B vaccine series (manufacturer unknown) and an unknown TD (manufacturer unknown). In approximately 2007, 2 or 3 years ago, the patient developed Behcet's disease after vaccination. The patient has seen a physician for medical attention. At the time of this report, the patient was not symptomatic. Additional information has been requested.
Dizziness, off-balance, vestibular issues On going symptoms. Still having them after a week and a half
pt recvd vax;c/o tremors,movement dis;shaky;incordination,somewhat lightheaded w/in couple of wks p/vax;difficulty ambulating,poor balance;some n,no fever,chills or sxs suggesting viral illness;feels weak all over;cholesterol=278;bil=1.1;